24/7 Market News Snapshot 17 October, 2025 – Sight Sciences, Inc. Common Stock (NASDAQ:SGHT)

October 17, 2025

DENVER, Colo., 17 October, 2025 (www.247marketnews.com) – (NASDAQ:SGHT) are discussed in this article.
Sight Sciences, Inc. has experienced a remarkable surge in its stock, opening at $3.90 and climbing to $4.51, reflecting a robust 30.78% increase in value. This rise, following a previous close of $3.45, signifies a strong bullish sentiment among investors, supported by a trading volume of 547.18K. As the market dynamics shift, this performance indicates potential further gains for traders and investors, underlining the company’s position as a notable player in the medical technology sector.

In a groundbreaking development, Sight Sciences has announced enhanced accessibility for its TearCare® System, an innovative solution for treating evaporative dry eye disease. As of January 1, 2025, two Medicare Administrative Contractors (MACs), Novitas Solutions, Inc. and First Coast Service Options, Inc. (FCSO), will implement jurisdiction-wide pricing for CPT® code 0563T, which pertains to the evacuation of meibomian glands utilizing TearCare technology. This pricing adjustment signals a pivotal improvement in access to essential treatment for an estimated 10.4 million covered lives across the MAC areas, accounting for roughly 30% of the total Medicare fee-for-service demographic when deemed necessary by healthcare providers.

Paul Badawi, the Co-Founder and CEO of Sight Sciences, expressed appreciation towards the eyecare community and the collaborating MACs for their role in facilitating access to the TearCare procedure. He highlighted the company’s ongoing commitment to engage with third-party payors and clinical societies to ensure patient access to this vital treatment.

To assist eyecare providers further, Sight Sciences has unveiled the Sight Access Portal, designed to streamline patient benefit verifications and address reimbursement inquiries. As the company prepares for its third-quarter earnings call, it anticipates sharing updated financial guidance to reflect these significant advancements, reaffirming its dedication to transforming eye care and enhancing patient outcomes.

Related news for (SGHT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.